Advances in in vitro and in silico approaches are reshaping drug development by improving the prediction of efficacy, safety and pharmacokinetics. This workshop will focus on two priority targets identified in the UK Government’s 2025 alternative methods strategy: reducing reliance on animal studies in pharmacokinetic and cardiovascular safety studies.

Sessions will bring together scientists and stakeholders to discuss the current landscape and identify gaps and opportunities where replacement technologies could improve study outcomes, increase human relevance and minimise animal use. The outputs will help to define how the Government targets can be delivered in practice through supporting research collaboration and innovation.

Registration closes: Friday 27 February.